Statins and nasal polyps [5]

Annals of Internal Medicine

Volumn 142, Issue 4, 2005, Pages 310-311

  Bucca, Caterina ^a   Marsico, Andrea ^a   Panaro, Erika ^a   Bigo, Patrizia ^b   Brussino, Luisa ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ASTHMA; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; EOSINOPHIL; FEMALE; HUMAN; LETTER; NEUTROPHIL; NOSE POLYP; PRIORITY JOURNAL; RHINOSINUSITIS; SKIN TEST; SURGICAL TECHNIQUE;

EID: 13444270387     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-142-4-200502150-00024     Document Type: Letter

References (5)

1. Bachert C, Van Cawenberge P. Nasal polyps and sinusitis. In: Adkinson NF, Yunginger JW, Busse WB, Bochner BS, Holgate ST, Simons FE, eds. Middleton's Allergy. Principles & Practice, 6th Edition. St. Louis: Mosby; 2003:1421-36.
2. Steinke JW, Bradley D, Arango P, Crouse CD, Frierson H, Kountakis SE, et al. Cysteinyl leukotriene expression in chronic hyperplastic sinusitis-nasal polyposis: importance to eosinophilia and asthma. J Allergy Clin Immunol. 2003;111:342-9.
3. Hakamada-Taguchi R, Uehara Y, Kuribayashi K, Numabe A, Saito K, Negoro H, et al. Inhibition of hydroxymethylglutaryl-coenzyme a reductase reduces Th1 development and promotes Th2 development. Circ Res. 2003;93:948-56.
4. Nath N, Giri S, Prasad R, Singh AK, Singh I. Potential targets of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor for multiple sclerosis therapy. J Immunol. 2004;172:1273-86.
5. Youssef S, Stuve O, Patarroyo JC, Ruiz PJ, Radosevich JL, Hur EM, et al. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature. 2002;420:78-84.